Left atrial appendage closure: which patients benefit most?
Chairperson: Maurice BUCHBINDER, Alec VAHANIAN
Objectives:
To learn which patients may benefit from left atrial appendage closureTo understand how to best balance the risk of stroke and bleeding in specific patient groups
To know the latest clinical evidence, guidelines and expert consensus recommendations on left atrial appendage closure
Lectures
Session objectives
M. Buchbinder
"My patient had a stroke and cannot take oral anticoagulation long-term"
M.W. Bergmann
"My patient has severe renal failure and a high CHA2DS2-VASc score"
I. Cruz-Gonzalez
"My patient has a stent and a high stroke risk"
H. SievertMore from Boston Scientific
Wrap up:
Role of LAA Closure therapy in stroke prevention for patients with Atrial Fibrillation
Discussants: Ted FELDMAN, Martin BERGMANN
The Lotus valve: advancing treatment options for patients with challenging anatomies
Chairperson: Ted Feldman
Optimal healing and DAPT duration in today’s complex PCI: the Synergy stent
Chairperson: Ian T. MEREDITH